Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells

The differentiation of pluripotent stem cells to hepatocytes is well established, yet current methods suffer from several drawbacks. These include a lack of definition and reproducibility, which in part stems from continued reliance on recombinant growth factors. This has remained a stumbling block...

Full description

Bibliographic Details
Main Authors: Richard Siller, Sebastian Greenhough, Elena Naumovska, Gareth J. Sullivan
Format: Article
Language:English
Published: Elsevier 2015-05-01
Series:Stem Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213671115001010
id doaj-dfd2242b8b684930baa4ddd8d67a9fdc
record_format Article
spelling doaj-dfd2242b8b684930baa4ddd8d67a9fdc2020-11-25T01:57:23ZengElsevierStem Cell Reports2213-67112015-05-014593995210.1016/j.stemcr.2015.04.001Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem CellsRichard Siller0Sebastian Greenhough1Elena Naumovska2Gareth J. Sullivan3Department of Biochemistry, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, NorwayDepartment of Biochemistry, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, NorwayDepartment of Biochemistry, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, NorwayDepartment of Biochemistry, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, NorwayThe differentiation of pluripotent stem cells to hepatocytes is well established, yet current methods suffer from several drawbacks. These include a lack of definition and reproducibility, which in part stems from continued reliance on recombinant growth factors. This has remained a stumbling block for the translation of the technology into industry and the clinic for reasons associated with cost and quality. We have devised a growth-factor-free protocol that relies on small molecules to differentiate human pluripotent stem cells toward a hepatic phenotype. The procedure can efficiently direct both human embryonic stem cells and induced pluripotent stem cells to hepatocyte-like cells. The final population of cells demonstrates marker expression at the transcriptional and protein levels, as well as key hepatic functions such as serum protein production, glycogen storage, and cytochrome P450 activity.http://www.sciencedirect.com/science/article/pii/S2213671115001010
collection DOAJ
language English
format Article
sources DOAJ
author Richard Siller
Sebastian Greenhough
Elena Naumovska
Gareth J. Sullivan
spellingShingle Richard Siller
Sebastian Greenhough
Elena Naumovska
Gareth J. Sullivan
Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
Stem Cell Reports
author_facet Richard Siller
Sebastian Greenhough
Elena Naumovska
Gareth J. Sullivan
author_sort Richard Siller
title Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
title_short Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
title_full Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
title_fullStr Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
title_full_unstemmed Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
title_sort small-molecule-driven hepatocyte differentiation of human pluripotent stem cells
publisher Elsevier
series Stem Cell Reports
issn 2213-6711
publishDate 2015-05-01
description The differentiation of pluripotent stem cells to hepatocytes is well established, yet current methods suffer from several drawbacks. These include a lack of definition and reproducibility, which in part stems from continued reliance on recombinant growth factors. This has remained a stumbling block for the translation of the technology into industry and the clinic for reasons associated with cost and quality. We have devised a growth-factor-free protocol that relies on small molecules to differentiate human pluripotent stem cells toward a hepatic phenotype. The procedure can efficiently direct both human embryonic stem cells and induced pluripotent stem cells to hepatocyte-like cells. The final population of cells demonstrates marker expression at the transcriptional and protein levels, as well as key hepatic functions such as serum protein production, glycogen storage, and cytochrome P450 activity.
url http://www.sciencedirect.com/science/article/pii/S2213671115001010
work_keys_str_mv AT richardsiller smallmoleculedrivenhepatocytedifferentiationofhumanpluripotentstemcells
AT sebastiangreenhough smallmoleculedrivenhepatocytedifferentiationofhumanpluripotentstemcells
AT elenanaumovska smallmoleculedrivenhepatocytedifferentiationofhumanpluripotentstemcells
AT garethjsullivan smallmoleculedrivenhepatocytedifferentiationofhumanpluripotentstemcells
_version_ 1724974440710668288